Published in Proc Natl Acad Sci U S A on January 21, 2005
Structural basis of integrin regulation and signaling. Annu Rev Immunol (2007) 8.60
Discriminating gene expression profiles of memory B cell subpopulations. J Exp Med (2008) 2.00
Structure of an integrin with an alphaI domain, complement receptor type 4. EMBO J (2009) 1.70
Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling. Blood (2011) 1.59
Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction. Mol Cell Biol (2006) 1.48
The 1.5 Å crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding. J Biol Chem (2010) 1.16
Recombinant human activated protein C inhibits integrin-mediated neutrophil migration. Blood (2009) 1.11
Historical perspective and future directions in platelet research. J Thromb Haemost (2011) 1.06
Probing the functional heterogeneity of surface binding sites by analysis of experimental binding traces and the effect of mass transport limitation. Biophys J (2006) 1.06
Shape change in the receptor for gliding motility in Plasmodium sporozoites. Proc Natl Acad Sci U S A (2012) 0.97
β2 integrin mediates hantavirus-induced release of neutrophil extracellular traps. J Exp Med (2014) 0.96
Binding between the integrin alphaXbeta2 (CD11c/CD18) and heparin. J Biol Chem (2007) 0.95
Structural insight on the recognition of surface-bound opsonins by the integrin I domain of complement receptor 3. Proc Natl Acad Sci U S A (2013) 0.95
Molecular basis for complement recognition by integrin αXβ2. Proc Natl Acad Sci U S A (2012) 0.90
Bayesian analysis of heterogeneity in the distribution of binding properties of immobilized surface sites. Langmuir (2008) 0.86
Integrin CD11c/CD18 α-chain phosphorylation is functionally important. J Biol Chem (2013) 0.82
Structure and binding interface of the cytosolic tails of αXβ2 integrin. PLoS One (2012) 0.80
The connection between metal ion affinity and ligand affinity in integrin I domains. Biochim Biophys Acta (2007) 0.79
Innate Immunity and Biomaterials at the Nexus: Friends or Foes. Biomed Res Int (2015) 0.78
Glatiramer acetate in treatment of multiple sclerosis: a toolbox of random co-polymers for targeting inflammatory mechanisms of both the innate and adaptive immune system? Int J Mol Sci (2012) 0.78
CD11c/CD18 Dominates Adhesion of Human Monocytes, Macrophages and Dendritic Cells over CD11b/CD18. PLoS One (2016) 0.77
Integrins Influence the Size and Dynamics of Signaling Microclusters in a Pyk2-dependent Manner. J Biol Chem (2015) 0.75
Structural Basis for Simvastatin Competitive Antagonism of Complement Receptor 3. J Biol Chem (2016) 0.75
Distinct recognition of complement iC3b by integrins αXβ2 and αMβ2. Proc Natl Acad Sci U S A (2017) 0.75
Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities? Mol Cell Ther (2013) 0.75
Expression of CD11c Is Associated with Unconventional Activated T Cell Subsets with High Migratory Potential. PLoS One (2016) 0.75
Eosinophils in the blood of hematopoietic stem cell transplanted patients are activated and have different molecular marker profiles in acute and chronic graft-versus-host disease. Immun Inflamm Dis (2014) 0.75
Mechanical forces in the immune system. Nat Rev Immunol (2017) 0.75
Molecular identification of a danger signal that alerts the immune system to dying cells. Nature (2003) 8.90
Pattern recognition receptors: doubling up for the innate immune response. Cell (2002) 4.84
Structural basis of collagen recognition by integrin alpha2beta1. Cell (2000) 4.84
Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18). Cell (1995) 4.73
Structures of the alpha L I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation. Cell (2003) 4.19
Danger signals: SOS to the immune system. Curr Opin Immunol (2001) 3.91
Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. Proc Natl Acad Sci U S A (1988) 3.25
Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest (2004) 2.57
Reversibly locking a protein fold in an active conformation with a disulfide bond: integrin alphaL I domains with high affinity and antagonist activity in vivo. Proc Natl Acad Sci U S A (2001) 2.35
Proteolysis and cell migration: creating a path? Curr Opin Cell Biol (1999) 2.19
p150/95, Third member of the LFA-1/CR3 polypeptide family identified by anti-Leu M5 monoclonal antibody. Eur J Immunol (1985) 2.14
Endothelial cells proactively form microvilli-like membrane projections upon intercellular adhesion molecule 1 engagement of leukocyte LFA-1. J Immunol (2003) 1.95
The alpha subunit cytoplasmic domain regulates the assembly and adhesiveness of integrin lymphocyte function-associated antigen-1. J Immunol (1997) 1.93
An isoleucine-based allosteric switch controls affinity and shape shifting in integrin CD11b A-domain. J Biol Chem (2000) 1.84
CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. Immunity (2002) 1.83
Epitope mapping of antibodies to the C-terminal region of the integrin beta 2 subunit reveals regions that become exposed upon receptor activation. J Immunol (2001) 1.78
CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the A alpha chain of fibrinogen. Proc Natl Acad Sci U S A (1991) 1.68
CD2 and the nature of protein interactions mediating cell-cell recognition. Immunol Rev (1998) 1.68
Two functional states of the CD11b A-domain: correlations with key features of two Mn2+-complexed crystal structures. J Cell Biol (1998) 1.67
Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD1). J Cell Biol (1995) 1.67
Order out of complexity--protein structures that interact with heparin. Curr Opin Struct Biol (2001) 1.45
The Mac-1 and p150,95 beta 2 integrins bind denatured proteins to mediate leukocyte cell-substrate adhesion. Exp Cell Res (1992) 1.38
Molecular packing of lysozyme, fibrinogen, and bovine serum albumin on hydrophilic and hydrophobic surfaces studied by infrared-visible sum frequency generation and fluorescence microscopy. J Am Chem Soc (2003) 1.36
Regulated unmasking of the cryptic binding site for integrin alpha M beta 2 in the gamma C-domain of fibrinogen. Biochemistry (2002) 1.30
A molecular basis for integrin alphaMbeta 2 ligand binding promiscuity. J Biol Chem (2002) 1.25
Recognition of fibrinogen by leukocyte integrins. Ann N Y Acad Sci (2001) 1.22
Combined affinity and rate constant distributions of ligand populations from experimental surface binding kinetics and equilibria. Biophys J (2003) 1.21
Real-time competitive kinetic analysis of interactions between low-molecular-weight ligands in solution and surface-immobilized receptors. Anal Biochem (1994) 1.19
Structure and allosteric regulation of the alpha X beta 2 integrin I domain. Proc Natl Acad Sci U S A (2003) 1.18
The incorporation of fibrinogen into extracellular matrix is dependent on active assembly of a fibronectin matrix. J Cell Sci (2002) 1.17
Portion-mixing peptide libraries of quenched fluorogenic substrates for complete subsite mapping of endoprotease specificity. Proc Natl Acad Sci U S A (1994) 1.11
Solvent-accessible residues on the metal ion-dependent adhesion site face of integrin CR3 mediate its binding to the neutrophil inhibitory factor. J Biol Chem (1996) 1.08
Matrix-fibrinogen enhances wound closure by increasing both cell proliferation and migration. Blood (2003) 1.08
Fibrinogen coating density affects the conformation of immobilized fibrinogen: implications for platelet adhesion and spreading. Thromb Haemost (1998) 1.06
Interactions of integrins with their partner proteins in leukocyte membranes. Immunol Res (2002) 1.05
Proximity oscillations of complement type 4 (alphaX beta2) and urokinase receptors on migrating neutrophils. Biophys J (1997) 1.04
Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 (alpha M beta 2' CD11b/CD18) during neutrophil polarization. J Immunol (1996) 1.04
Crystal structure of native chicken fibrinogen at 5.5-A resolution. Proc Natl Acad Sci U S A (2000) 1.00
Selective adhesion of macrophages to denatured forms of type I collagen is mediated by scavenger receptors. Matrix Biol (2000) 0.95
A homogeneous fluorometric assay for measuring cell adhesion to immobilized ligand using V-well microtiter plates. Anal Biochem (2001) 0.93
Spectroscopic studies of fibrinogen and its plasmin-derived fragments. Biochim Biophys Acta (1992) 0.79
Structural basis of integrin regulation and signaling. Annu Rev Immunol (2007) 8.60
Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell (2002) 7.03
Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature (2004) 5.87
Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science (2003) 5.58
Modern analytical ultracentrifugation in protein science: a tutorial review. Protein Sci (2002) 4.86
The genome of M. acetivorans reveals extensive metabolic and physiological diversity. Genome Res (2002) 4.58
Macromolecular size-and-shape distributions by sedimentation velocity analytical ultracentrifugation. Biophys J (2006) 4.06
Transcellular diapedesis is initiated by invasive podosomes. Immunity (2007) 4.06
Regulation of T cell receptor activation by dynamic membrane binding of the CD3epsilon cytoplasmic tyrosine-based motif. Cell (2008) 4.00
Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor. Science (2009) 3.85
Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature (2003) 3.77
Conformational regulation of integrin structure and function. Annu Rev Biophys Biomol Struct (2001) 3.74
Sedimentation equilibrium analysis of protein interactions with global implicit mass conservation constraints and systematic noise decomposition. Anal Biochem (2004) 3.71
A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J Cell Biol (2004) 3.66
Integrin avidity regulation: are changes in affinity and conformation underemphasized? Curr Opin Cell Biol (2003) 3.59
Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces. Mol Cell (2008) 3.54
Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target. Science (2008) 3.51
Latent TGF-β structure and activation. Nature (2011) 3.42
RIAM, an Ena/VASP and Profilin ligand, interacts with Rap1-GTP and mediates Rap1-induced adhesion. Dev Cell (2004) 3.27
Activation of leukocyte beta2 integrins by conversion from bent to extended conformations. Immunity (2006) 3.11
Structure of integrin alpha5beta1 in complex with fibronectin. EMBO J (2003) 2.99
Studying multiprotein complexes by multisignal sedimentation velocity analytical ultracentrifugation. Proc Natl Acad Sci U S A (2004) 2.74
Integrin activation and structural rearrangement. Immunol Rev (2002) 2.60
Recorded scan times can limit the accuracy of sedimentation coefficients in analytical ultracentrifugation. Anal Biochem (2013) 2.57
Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation. Nat Struct Biol (2002) 2.56
Studying multisite binary and ternary protein interactions by global analysis of isothermal titration calorimetry data in SEDPHAT: application to adaptor protein complexes in cell signaling. Protein Sci (2007) 2.44
Sedimentation velocity analysis of heterogeneous protein-protein interactions: Lamm equation modeling and sedimentation coefficient distributions c(s). Biophys J (2005) 2.39
Identification of the target self-antigens in reperfusion injury. J Exp Med (2006) 2.38
Conversion between three conformational states of integrin I domains with a C-terminal pull spring studied with molecular dynamics. Structure (2004) 2.35
Small molecule integrin antagonists that bind to the beta2 subunit I-like domain and activate signals in one direction and block them in the other. Immunity (2003) 2.34
Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1. Proc Natl Acad Sci U S A (2007) 2.27
A specific interface between integrin transmembrane helices and affinity for ligand. PLoS Biol (2004) 2.26
Calculating sedimentation coefficient distributions by direct modeling of sedimentation velocity concentration profiles. Methods Enzymol (2004) 2.24
The primacy of affinity over clustering in regulation of adhesiveness of the integrin {alpha}L{beta}2. J Cell Biol (2004) 2.22
Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody. J Biol Chem (2003) 2.19
The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood. Nat Immunol (2012) 2.17
Oligomerization of signaling complexes by the multipoint binding of GRB2 to both LAT and SOS1. Nat Struct Mol Biol (2006) 2.10
Integrin structures and conformational signaling. Curr Opin Cell Biol (2006) 2.03
Structure and assembly mechanism for heteromeric kainate receptors. Neuron (2011) 2.03
Archaeal surface layer proteins contain beta propeller, PKD, and beta helix domains and are related to metazoan cell surface proteins. Structure (2002) 2.00
Sedimentation velocity analysis of heterogeneous protein-protein interactions: sedimentation coefficient distributions c(s) and asymptotic boundary profiles from Gilbert-Jenkins theory. Biophys J (2005) 2.00
Rolling adhesion through an extended conformation of integrin alphaLbeta2 and relation to alpha I and beta I-like domain interaction. Immunity (2004) 1.98
Therapeutic antagonists and conformational regulation of integrin function. Nat Rev Drug Discov (2003) 1.98
Characterizing protein-protein interactions by sedimentation velocity analytical ultracentrifugation. Curr Protoc Immunol (2008) 1.97
Endothelial cells proactively form microvilli-like membrane projections upon intercellular adhesion molecule 1 engagement of leukocyte LFA-1. J Immunol (2003) 1.95
Stabilizing the open conformation of the integrin headpiece with a glycan wedge increases affinity for ligand. Proc Natl Acad Sci U S A (2003) 1.93
Bistable regulation of integrin adhesiveness by a bipolar metal ion cluster. Nat Struct Biol (2003) 1.92
High-precision isothermal titration calorimetry with automated peak-shape analysis. Anal Chem (2012) 1.92
Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor. Proc Natl Acad Sci U S A (2009) 1.91
A mechanically stabilized receptor-ligand flex-bond important in the vasculature. Nature (2010) 1.90
Importance of force linkage in mechanochemistry of adhesion receptors. Biochemistry (2006) 1.87
The structure of a receptor with two associating transmembrane domains on the cell surface: integrin alphaIIbbeta3. Mol Cell (2009) 1.82
Biochemical and biological characterization of a dodecameric CD4-Ig fusion protein: implications for therapeutic and vaccine strategies. J Biol Chem (2002) 1.79
On the distribution of protein refractive index increments. Biophys J (2011) 1.76
Nonmuscle myosin heavy chain IIA mediates integrin LFA-1 de-adhesion during T lymphocyte migration. J Exp Med (2008) 1.76
Remodeling of the lectin-EGF-like domain interface in P- and L-selectin increases adhesiveness and shear resistance under hydrodynamic force. Nat Immunol (2006) 1.74
The N-terminal domain of GluR6-subtype glutamate receptor ion channels. Nat Struct Mol Biol (2009) 1.73
Disrupting integrin transmembrane domain heterodimerization increases ligand binding affinity, not valency or clustering. Proc Natl Acad Sci U S A (2005) 1.73
Structure of an integrin with an alphaI domain, complement receptor type 4. EMBO J (2009) 1.70
Conformational restriction blocks glutamate receptor desensitization. Nat Struct Mol Biol (2006) 1.67
Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor. Mol Cell Biol (2010) 1.63
Complex between nidogen and laminin fragments reveals a paradigmatic beta-propeller interface. Nature (2003) 1.61
Transition from rolling to firm adhesion is regulated by the conformation of the I domain of the integrin lymphocyte function-associated antigen-1. J Biol Chem (2002) 1.61
Allosteric beta1 integrin antibodies that stabilize the low affinity state by preventing the swing-out of the hybrid domain. J Biol Chem (2004) 1.60
Structural transitions of complement component C3 and its activation products. Proc Natl Acad Sci U S A (2006) 1.57
Locking the beta3 integrin I-like domain into high and low affinity conformations with disulfides. J Biol Chem (2003) 1.56
RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice. Mol Ther (2009) 1.55
Measuring protein-protein interactions by equilibrium sedimentation. Curr Protoc Immunol (2007) 1.54
Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2K(b). Nat Immunol (2003) 1.54
Substrate stiffening promotes endothelial monolayer disruption through enhanced physical forces. Am J Physiol Cell Physiol (2010) 1.53
Requirement of alpha and beta subunit transmembrane helix separation for integrin outside-in signaling. Blood (2007) 1.52
Binding specificity of multiprotein signaling complexes is determined by both cooperative interactions and affinity preferences. Biochemistry (2004) 1.52
Intersubunit signal transmission in integrins by a receptor-like interaction with a pull spring. Proc Natl Acad Sci U S A (2004) 1.49
Functional and structural stability of the epidermal growth factor receptor in detergent micelles and phospholipid nanodiscs. Biochemistry (2008) 1.48
Regulation of integrin affinity on cell surfaces. EMBO J (2011) 1.47
Role for CCR7 ligands in the emigration of newly generated T lymphocytes from the neonatal thymus. Immunity (2002) 1.46
Cooperative interactions at the SLP-76 complex are critical for actin polymerization. EMBO J (2010) 1.45
Simultaneous visualization of the extracellular and cytoplasmic domains of the epidermal growth factor receptor. Nat Struct Mol Biol (2011) 1.45
Highly reinforced structure of a C-terminal dimerization domain in von Willebrand factor. Blood (2014) 1.44
Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus. Proc Natl Acad Sci U S A (2006) 1.44
Trans-cellular migration: cell-cell contacts get intimate. Curr Opin Cell Biol (2008) 1.42
Overview of current methods in sedimentation velocity and sedimentation equilibrium analytical ultracentrifugation. Curr Protoc Protein Sci (2013) 1.41
Efficient neutralization of anthrax toxin by chimpanzee monoclonal antibodies against protective antigen. J Infect Dis (2006) 1.40